Edition:
United States

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

830.05INR
6:29am EDT
Change (% chg)

Rs-1.55 (-0.19%)
Prev Close
Rs831.60
Open
Rs835.80
Day's High
Rs841.00
Day's Low
Rs821.15
Volume
300,710
Avg. Vol
306,711
52-wk High
Rs1,063.00
52-wk Low
Rs671.10

Chart for

About

Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs153,424.70
Shares Outstanding(Mil.): 184.49
Dividend: 7.00
Yield (%): 0.99

Financials

  NATP.NS Industry Sector
P/E (TTM): 21.40 29.97 34.18
EPS (TTM): 38.86 -- --
ROI: 28.93 13.65 13.17
ROE: 29.49 15.43 15.15

BRIEF-Natco Pharma Files ANDA to U.S. FDA For Sofosbuvir Tablets

* SAYS FILED AN ABBREVIATED NEW DRUG APPLICATION FOR SOFOSBUVIR TABLETS, 400MG, WITH U.S.‍​ FDA

Mar 01 2018

BRIEF-Gilead: Natco And Teva Requested FDA Permission To Make Generic Version Of Sovaldi - SEC Filing

* GILEAD SCIENCES INC SAYS IN FEBRUARY 2018, CO RECEIVED NOTICES FROM NATCO PHARMA LIMITED AND TEVA PHARMA - SEC FILING

Feb 27 2018

BRIEF-Natco Pharma Says Co's Mekaguda Facility Undergoing Routine U.S. FDA Inspection

* NATCO PHARMA CLARIFIES ON NEWS ITEM ON US FDA INSPECTION AT CO'S MEKAGUDA FACILITY IN TELANGANA

Feb 14 2018

BRIEF-India's Natco Pharma Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL NET PROFIT 2.18 BILLION RUPEES VERSUS PROFIT 1.95 BILLION RUPEES YEAR AGO

Feb 06 2018

Earnings vs. Estimates